Rearrangements of the anaplastic lymphoma kinase (ALK) gene are present in 3% to 5% of NSCLC [72] and typically occur in younger patients who have never smoked or have a history of light smoking and that have adenocarcinoma histotype [73]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.